# the Effect of Ginkgo Biloba on Rheumatoid Arthritis Patients

> **NCT07709312** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Ain Shams University** · enrollment: 50 (estimated)

## Conditions studied

- Rheumatoid Arthritis (RA)
- Manegmentof Rheumatoid Arthritis

## Interventions

- **DRUG:** Ginkgo Biloba Extract (120 mg ) manufuctured by EMA PHARM

## Key facts

- **NCT ID:** NCT07709312
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-15
- **Primary completion:** 2027-01-15
- **Final completion:** 2027-01-15
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07709312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07709312, "the Effect of Ginkgo Biloba on Rheumatoid Arthritis Patients". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07709312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*